Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 12 of 15

 
 

Encompass Health (NYSE:EHC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$107.67 (5.8% Upside)

About Encompass Health

Encompass Health logoEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. More about Encompass Health
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
2/11/2025Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
2/10/2025KeyCorpBoost Price TargetOverweight ➝ Overweight$117.00 ➝ $120.00
2/7/2025BarclaysBoost Price TargetOverweight ➝ Overweight$116.00 ➝ $118.00
2/7/2025William BlairReiterated RatingOutperform
10/30/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $110.00
10/30/2024Truist FinancialReiterated RatingBuy ➝ Buy$108.00 ➝ $116.00
10/29/2024BarclaysBoost Price TargetOverweight ➝ Overweight$109.00 ➝ $116.00
10/29/2024KeyCorpBoost Price TargetOverweight ➝ Overweight$115.00 ➝ $117.00
10/14/2024Truist FinancialBoost Price TargetBuy ➝ Buy$104.00 ➝ $108.00
10/11/2024KeyCorpInitiated CoverageOverweight$115.00